OXYGENTA PHARMACEUTICAL LTD - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Oxygenta Pharmaceutical Ltd - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Download	< Back
26 Aug 2022
In compliance with provisions of Regulation 39(3)of SEBI (LODR) Regulations, 2015 read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD RTAMB/P/CIR/2022/8 dated 25 January 2022, the Company hereby inform that Letter of Confirmation has been issued to the below mentioned shareholder for effecting issuance of Duplicate Share Certificate in dematerialized mode We request you to kindly take the same on record. Thanking you
View all announcements for Oxygenta Pharmaceutical Ltd	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us